Dorota M Gertig

Prognostic gene expression signature for high-grade serous ovarian cancer

J Millstein, T Budden, EL Goode, MS Anglesio, A Talhouk, MP Intermaggio, HS Leong, S Chen, W Elatre, B Gilks, T Nazeran, M Volchek, RC Bentley, C Wang, DS Chiu, S Kommoss, SCY Leung, J Senz, A Lum, V Chow, et al.

Journal article  |  2020  |  Annals of Oncology

BACKGROUND: Median overall survival (OS) for women with high-grade serous ovarian cancer (HGSOC) is ∼4 years, yet survival varies ..

Management and long-term outcomes of women with adenocarcinoma in situ of the cervix: A retrospective study

Jeffrey HJ Tan, Michael J Malloy, Ramaish Thangamani, Dorota Gertig, Kelly T Drennan, C David Wrede, Marion Saville, Michael Quinn

Journal article  |  2019  |  Australian and New Zealand Journal of Obstetrics and Gynaecology

BRAF Mutations in Low-Grade Serous Ovarian Cancer and Response to BRAF Inhibition

Tania Moujaber, Dariush Etemadmoghadam, Catherine J Kennedy, Yoke-Eng Chiew, Rosemary L Balleine, Catherine Saunders, Gerard Wain, Bo Gao, Russell Hogg, Sivatharsny Srirangan, Casina Kan, Sian Fereday, Nadia Traficante, Ann-Marie Patch, John Pearson, Nicola Waddell, Sean M Grimmond, Alexander Dobrovic, David DL Bowtell, Paul R Harnett, et al.

Journal article  |  2018  |  JCO Precision Oncology

Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial

Karen Canfell, Michael Caruana, Val Gebski, Jessica Darlington-Brown, Stella Heley, Julia Brotherton, Dorota Gertig, Chloe J Jennett, Annabelle Farnsworth, Jeffrey Tan, C David Wrede, Philip E Castle, Marion Saville

Journal article  |  2017  |  PLoS Medicine

Time to clinical investigation for Indigenous and non-Indigenous Queensland women after a high grade abnormal Pap smear, 2000-2009

Lisa J Whop, Peter D Baade, Julia ML Brotherton, Karen Canfell, Joan Cunningham, Dorota Gertig, Kamalini Lokuge, Gail Garvey, Suzanne P Moore, Abbey Diaz, Dianne L O'Connell, Patricia Valery, David M Roder, John R Condon

Journal article  |  2017  |  The Medical Journal of Australia

Genetic and Environmental Factors in Invasive Cervical Cancer: Design and Methods of a Classical Twin Study

Dorothy A Machalek, John D Wark, Sepehr N Tabrizi, John L Hopper, Minh Bui, Gillian S Dite, Alyssa M Cornall, Marian Pitts, Dorota Gertig, Bircan Erbas, Suzanne M Garland

Journal article  |  2017  |  Twin Research and Human Genetics

Home-based HPV self-sampling improves participation by never-screened and under-screened women: Results from a large randomized trial (iPap) in Australia

F Sultana, DR English, JA Simpson, KT Drennan, R Mullins, JML Brotherton, CD Wrede, S Heley, M Saville, DM Gertig

Journal article  |  2016  |  International Journal of Cancer

The first comprehensive report on Indigenous Australian women's inequalities in cervical screening: A retrospective registry cohort study in Queensland, Australia (2000-2011)

Lisa J Whop, Gail Garvey, Peter Baade, Joan Cunningham, Kamalini Lokuge, Julia ML Brotherton, Patricia C Valery, Dianne L O'Connell, Karen Canfell, Abbey Diaz, David Roder, Dorota Gertig, Suzanne P Moore, John R Condon

Journal article  |  2016  |  Cancer

Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use

Megan A Smith, Dorota Gertig, Michaela Hall, Kate Simms, Jie-Bin Lew, Michael Malloy, Marion Saville, Karen Canfell

Journal article  |  2016  |  BMC Health Services Research

Cervical Abnormalities Are More Common among Indigenous than Other Australian Women: A Retrospective Record-Linkage Study, 2000-2011

Lisa J Whop, Peter Baade, Gail Garvey, Joan Cunningham, Julia ML Brotherton, Kamalini Lokuge, Patricia C Valery, Dianne L O'Connell, Karen Canfell, Abbey Diaz, David Roder, Dorota M Gertig, Suzanne P Moore, John R Condon

Journal article  |  2016  |  PLoS One